Functional MxA promoter polymorphism associated with subacute sclerosing panencephalitis

Neurology

Volumn 62, Issue 3, 2004, Pages 457-460

  Torisu, H ^a   Kusuhara, K ^a   Kira, R ^a   Bassuny, W M ^a   Sakai, Y ^a   Sanefuji, M ^a   Takemoto, M ^a   Hara, T ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; MYXOVIRUS RESISTANCE PROTEIN A; PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ALLELE; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE LINKAGE DISEQUILIBRIUM; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HOMOZYGOSITY; HUMAN; HUMAN CELL; JAPAN; MALE; MEASLES; MEASLES VIRUS; MXA GENE; NUCLEOTIDE SEQUENCE; PERSISTENT VIRUS INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RNA VIRUS; SINGLE NUCLEOTIDE POLYMORPHISM; SUBACUTE SCLEROSING PANENCEPHALITIS; UPREGULATION; VIRUS INHIBITION;

EID: 1042288149     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000106940.95749.8E     Document Type: Article

References (20)

1. Kai C, Yamanouchi K, Miyashita N, Takahashi H, Kobune F. Nucleotide sequences of M gene of prevailing wild measles viruses and a comparison with subacute sclerosing panencephalitis virus. Virus Genes 1996;12:85-87.
2. Jin L, Beard S, Hunjan R, Brown D, Miller E. Characterization of measles virus strains causing SSPE: a study of 11 cases. J Neurovirol 2002;8:335-344.
3. Gascon GC. Subacute sclerosing panencephalitis. Semin Pediatr Neurol 1996;3:260-269.
4. Schneider-Schaulies J, Niewiesk S, Schneider-Schaulies S, ter Meulen V. Measles virus in the CNS: the role of viral and host factors for the establishment and maintenance of a persistent infection. J Neurovirol 1999;5:613-622.
5. Inoue T, Kira R, Nakao F, et al. Contribution of the interleukin-4 gene to susceptibility to subacute sclerosing panencephalitis. Arch Neurol 2002;59:822-827.
6. Hara T, Yamashita S, Aiba H, et al. Measles virus-specific T helper 1/T helper 2-cytokine production in subacute sclerosing panencephalitis. J Neurovirol 2000;6:121-126.
7. Kusuhara K, Sasaki Y, Nakao F, et al. Analysis of measles virus-binding sites of CD46 gene in patients with subacute sclerosing panencephalitis. J Infect Dis 2000;181:1447-1449.
8. Schnorr JJ, Schneider-Schaulies S, Simon-Jodicke A, Pavlovic J, Horisberger MA, ter Meulen V. MxA-dependent inhibition of measles virus glycoprotein synthesis in a stably transfected human monocytic cell line. J Virol 1993;67:4760-4768.
9. Schneider-Schaulies S, Schneider-Schaulies J, Schuster A, Bayer M, Pavlovic J, ter Meulen V. Cell type-specific MxA-mediated inhibition of measles virus transcription in human brain cells. J Virol 1994;68:6910-6917.
10. ter Meulen V. Molecular and cellular aspects of measles virus persistence in the CNS. J Neurovirol 1997;3:S3-S5.
11. Ronni T, Matikainen S, Lehtonen A, et al. The proximal interferon-stimulated response elements are essential for interferon responsiveness: a promoter analysis of the antiviral MxA gene. J Interferon Cytokine Res 1998;18:773-781.
12. Chang KC, Hansen E, Foroni L, Lida J, Goldspink G. Molecular and functional analysis of the virus- and interferon-inducible human MxA promoter. Arch Virol 1991;117:1-15.
13. Hijikata M, Ohta Y, Mishiro S. Identification of a single nucleotide polymorphism in the MxA gene promoter (G/T at nt -88) correlated with the response of hepatitis C patients to interferon. Intervirology 2000;43:124-127.
14. Hijikata M, Mishiro S, Miyamoto C, Furuichi Y, Hashimoto M, Ohta Y. Genetic polymorphism of the MxA gene promoter and IFN responsiveness of hepatitis C patients: revisited by analyzing two SNP sites (-123 and -88) in vivo and in vitro. Intervirology 2001;44:379-382.
15. Nakayama T, Mori T, Yamaguchi S, et al. Detection of measles virus genome directly from clinical samples by reverse transcriptase-polymerase chain reaction and genetic variability. Virus Res 1995;35: 1-16.
16. Schneider-Schaulies J, Schneider-Schaulies S, ter Meulen V. Differential induction of cytokines by primary and persistent measles virus infections in human glial cells. Virology 1993;195:219-228.
17. Naniche D, Yeh A, Eto D, Manchester M, Friedman RM, Oldstone MB. Evasion of host defenses by measles virus: wild-type measles virus infection interferes with induction of alpha/beta interferon production. J Virol 2000;74:7478-7484.
18. Shiozawa S, Yoshikawa N, Iijima K, Negishi K. A sensitive radioimmunoassay for circulating alpha-interferon in the plasma of healthy children and patients with measles virus infection. Clin Exp Immunol 1988;73:366-369.
19. Finke D, Brinckmann UG, ter Meulen V, Liebert UG. Gamma interferon is a major mediator of antiviral defense in experimental measles virus-induced encephalitis. J Virol 1995;69:5469-5474.
20. Patterson CE, Lawrence DM, Echols LA, Rall GF. Immune-mediated protection from measles virus-induced central nervous system disease is noncytolytic and gamma interferon dependent. J Virol 2002;76:4497-4506.